Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Synsam ABOSTO:SYNSAM +7.50%83 5-Year Yield-on-Cost % is 3.25 as of Aug. 22, 2026, which is 8% below its 10-year median of 3.54. GuruFocus rates OSTO:SYNSAM with a GF Score™ of 83/100 and a GF Value™ of kr61.02 (Fairly Valued). The stock has 1 warning sign investors should review. Among 315 Medical Devices & Instruments companies, Synsam AB ranks better than 60.95% on this metric.
Synsam AB's yield on cost for the quarter that ended in Jun. 2026 was 3.25.
The historical rank and industry rank for Synsam AB's 5-Year Yield-on-Cost % or its related term are showing as below:
OSTO:SYNSAM'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 2.58 Med: 3.54 Max: 5.07
Current: 3.25
During the past 8 years, Synsam AB's highest Yield on Cost was 5.07. The lowest was 2.58. And the median was 3.54.
OSTO:SYNSAM's 5-Year Yield-on-Cost % is ranked better than 60.95% of 315
companies
in the Medical Devices & Instruments industry
Industry Median: 2.4
vs OSTO:SYNSAM: 3.25
Synsam AB (OSTO:SYNSAM) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Synsam AB 5-Year Yield-on-Cost % Related Terms
OSTO:SYNSAM vs ISRG, BDX, MDLN: 5-Year Yield-on-Cost % Comparison
For the Medical Instruments & Supplies subindustry, Synsam AB's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synsam AB 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Synsam AB's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Synsam AB's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Synsam AB is calculated as
Synsam AB (OSTO:SYNSAM) has a 5-Year Yield-on-Cost % of 3.25 as of Aug. 22, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Synsam AB and its competitors. This is near median its historical median of 3.54. Over the past decade, Synsam AB's 5-Year Yield-on-Cost % has ranged from 2.58 to 5.07. According to the industry distribution chart, Synsam AB ranks #123 out of 315 companies in the Medical Devices & Instruments industry, placing it in the top 39%.
Is Synsam AB's 5-Year Yield-on-Cost % too high?
Synsam AB's current 5-Year Yield-on-Cost % of 3.25 is near median its 10-year median of 3.54. Over the past 10 years, this metric has ranged from a low of 2.58 to a high of 5.07. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.40. Synsam AB's value of 3.25 is 35.4% above this industry median. Based on the distribution chart, Synsam AB ranks #123 out of 315 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Synsam AB has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Synsam AB's 5-Year Yield-on-Cost % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Synsam AB ranks #123 out of 315 companies for 5-Year Yield-on-Cost %. This puts Synsam AB in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 2.40. Synsam AB's value of 3.25 is 35.4% above this benchmark. Historically, Synsam AB's own 5-Year Yield-on-Cost % has ranged from 2.58 to 5.07 over the past decade. While the company's 10-year median is 3.54 vs. the industry median of 2.40, Synsam AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.40, based on 315 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Synsam AB's current 5-Year Yield-on-Cost % of 3.25 is 35.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Synsam AB and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synsam AB's current 5-Year Yield-on-Cost % is 3.25, which is near median its own 10-year median of 3.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synsam AB stock overvalued right now?
Based on GuruFocus' analysis, Synsam AB (OSTO:SYNSAM) is currently considered Fairly Valued. The stock's GF Value™ is kr61.02, compared to a current price of kr60.20 — trading 1.3% below its estimated fair value. The current 5-Year Yield-on-Cost % is 3.25, which is near median its 10-year median of 3.54 and 35.4% above the Medical Devices & Instruments industry median of 2.40. Synsam AB's overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Synsam AB (OSTO:SYNSAM), the current 5-Year Yield-on-Cost % is 3.25 as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Synsam AB (OSTO:SYNSAM) Overvalued in 2026?
Based on GuruFocus' analysis, Synsam AB stock appears to be undervalued.
The current stock price of kr60.20 is trading 1.3% below its estimated GF Value™ of kr61.02.
GuruFocus considers Synsam AB to be Fairly Valued.
Key valuation signals for OSTO:SYNSAM:
5-Year Yield-on-Cost %: 3.25 (near median its 10-year median of 3.54)
GF Value™: kr61.02 vs. price of kr60.20 (1.3% below fair value)
Industry Position: 35.4% above the Medical Devices & Instruments median (#123 of 315)
No single metric tells the full story. See the OSTO:SYNSAM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Synsam AB is a lifestyle company in optics and eye health in the Nordic region. The company offers various products and services in physical and digital stores, such as eye examinations, spectacles, sunglasses, sports spectacles, contact lenses, and accessories in optical retail, as well as spectacles subscriptions and related services under the name Synsam Lifestyle. Its stores are operated under the Synsam brand in Sweden, Norway, and Finland, and under the Profil Optik brand in Denmark and Iceland. The company comprises four segments: Sweden, which generates key revenue, Denmark, Norway, and Finland.
83GF Score
Get the complete analysis for OSTO:SYNSAM
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:SYNSAM has been successfully added to your 
